Intermediate for Pomalidomide. Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.
Product Name: 4-Nitrothalidomide
CAS Number: 19171-18-7
Molecular Weight:  303.2306
Molecular Formula:  C13H9N3O6
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.